Myasthenia gravis: subgroup classifications

Affiliations

¹ Department of Experimental Neurology, NeuroCure Clinical Research Center, and Department of Neurology, Charité-University Medicine Berlin, Berlin, 10117, Germany. Electronic address: siegfried.kohler@charite.de.
² Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
³ Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, 10117, Germany.
⁴ Department of Experimental Neurology, NeuroCure Clinical Research Center, and Department of Neurology, Charité-University Medicine Berlin, Berlin, 10117, Germany.

Comment

Siegfried Kohler et al. Lancet Neurol. 2016 Apr.

. 2016 Apr;15(4):356-7.

doi: 10.1016/S1474-4422(16)00033-8.

¹ Department of Experimental Neurology, NeuroCure Clinical Research Center, and Department of Neurology, Charité-University Medicine Berlin, Berlin, 10117, Germany. Electronic address: siegfried.kohler@charite.de.
² Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
³ Department of Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, 10117, Germany.
⁴ Department of Experimental Neurology, NeuroCure Clinical Research Center, and Department of Neurology, Charité-University Medicine Berlin, Berlin, 10117, Germany.

No abstract available

Comment in

Myasthenia gravis: subgroup classifications - Authors' reply.
Gilhus NE, Verschuuren JJ. Gilhus NE, et al. Lancet Neurol. 2016 Apr;15(4):357-8. doi: 10.1016/S1474-4422(16)00035-1. Lancet Neurol. 2016. PMID: 26971656 No abstract available.

Myasthenia gravis: subgroup classification and therapeutic strategies.
Gilhus NE, Verschuuren JJ. Gilhus NE, et al. Lancet Neurol. 2015 Oct;14(10):1023-36. doi: 10.1016/S1474-4422(15)00145-3. Lancet Neurol. 2015. PMID: 26376969 Review.